{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:31:06Z","timestamp":1779377466943,"version":"3.53.1"},"reference-count":254,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011045","name":"Ministere de l'Enseignement superieur de la Recherche et de l'Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Gerontology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.exger.2021.111452","type":"journal-article","created":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T03:21:31Z","timestamp":1624677691000},"page":"111452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["New frontiers in Alzheimer's disease diagnostic: Monoamines and their derivatives in biological fluids"],"prefix":"10.1016","volume":"152","author":[{"given":"Alessandra","family":"Gallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure-Elise","family":"Pillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Verpillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb0005","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1192\/bjp.135.3.216","article-title":"Changes in the brain catecholamines in patients with dementia of Alzheimer type","volume":"135","author":"Adolfsson","year":"1979","journal-title":"Br. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.exger.2021.111452_bb0010","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/0024-3205(80)90025-9","article-title":"Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type","volume":"27","author":"Adolfsson","year":"1980","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.exger.2021.111452_bb0015","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3233\/JAD-2011-110482","article-title":"CSF tau, A\u03b242, and MHPG differentiate dementia with Lewy bodies from Alzheimer\u2019s disease","volume":"27","author":"Aerts","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.exger.2021.111452_bb0020","article-title":"Platelets: peripheral biomarkers of dementia?","volume":"May","author":"Akingbade","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb0025","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dementia J. Alzheimers Assoc."},{"issue":"5","key":"10.1016\/j.exger.2021.111452_bb0040","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/nan.12386","article-title":"Locus coeruleus at asymptomatic early and middle Braak stages of neurofibrillary tangle pathology","volume":"43","author":"Andr\u00e9s-Benito","year":"2017","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"2","key":"10.1016\/j.exger.2021.111452_bb0045","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1471-4159.1984.tb00913.x","article-title":"Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia","volume":"43","author":"Arai","year":"1984","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00313207","article-title":"Dopamine (DA) and serotonin metabolic levels in the cerebrospinal fluid (CSF) in Alzheimer\u2019s presenile dementia under basic conditions and after stimulation with cerebral cortex phospholipids (BC-PL)","volume":"224","author":"Argentiero","year":"1980","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb0055","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3233\/JAD-181106","article-title":"Treatment of Alzheimer\u2019s disease: trazodone, sleep, serotonin, norepinephrine, and future directions","volume":"67","author":"Ashford","year":"2019","journal-title":"J. Alzheimers Dis."},{"issue":"1\u20133","key":"10.1016\/j.exger.2021.111452_bb0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0047-6374(00)00183-4","article-title":"Reduced density of dopamine D2-like receptors on peripheral blood lymphocytes in Alzheimer\u2019s disease","volume":"120","author":"Barbanti","year":"2000","journal-title":"Mech. Ageing Dev."},{"issue":"11","key":"10.1016\/j.exger.2021.111452_bb0065","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/archneur.1982.00510230035010","article-title":"Decreased CSF concentrations of homovanillic acid and gamma-aminobutyric acid in Alzheimer\u2019s disease. Age- or disease-related modifications?","volume":"39","author":"Bareggi","year":"1982","journal-title":"Arch. Neurol."},{"issue":"12","key":"10.1016\/j.exger.2021.111452_bb0070","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/jcbfm.2012.115","article-title":"The locus coeruleus-norepinephrine network optimizes coupling of cerebral blood volume with oxygen demand","volume":"32","author":"Bekar","year":"2012","journal-title":"J. Cerebr. Blood Flow Metab. Off. J. Int. Soc. Cerebr. Blood Flow Metab."},{"key":"10.1016\/j.exger.2021.111452_bb0075","series-title":"Handbook of Chemical Neuroanatomy","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0924-8196(05)80005-3","article-title":"Chapter I the organization and circuits of Mesencephalic dopaminergic neurons and the distribution of dopamine receptors in the brain","volume":"21","author":"Bentivoglio","year":"2005"},{"key":"10.1016\/j.exger.2021.111452_bb0080","series-title":"Oxidative Stress and Neurodegenerative Disorders","first-page":"183","article-title":"Chapter 7 - redox imbalance: In the triad of genetic disturbances and mitochondrial dysfunction in Parkinson\u2019s disease","author":"Berg","year":"2007"},{"issue":"December","key":"10.1016\/j.exger.2021.111452_bb0085","first-page":"281","article-title":"Locus coeruleus MRI contrast is reduced in Alzheimer\u2019s disease dementia and correlates with CSF A\u03b2 levels","volume":"11","author":"Betts","year":"2019","journal-title":"Alzheimers Dementia Diagn. Assess. Dis. Monit."},{"issue":"9","key":"10.1016\/j.exger.2021.111452_bb0090","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1093\/brain\/awz193","article-title":"Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases","volume":"142","author":"Betts","year":"2019","journal-title":"Brain"},{"issue":"Suppl. 1","key":"10.1016\/j.exger.2021.111452_bb0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40120-017-0073-9","article-title":"A review of fluid biomarkers for Alzheimer\u2019s disease: moving from CSF to blood","volume":"6","author":"Blennow","year":"2017","journal-title":"Neurol. Ther."},{"issue":"6","key":"10.1016\/j.exger.2021.111452_bb0100","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/joim.12816","article-title":"Biomarkers for Alzheimer\u2019s disease: current status and prospects for the future","volume":"284","author":"Blennow","year":"2018","journal-title":"J. Intern. Med."},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb0105","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0197-4580(92)90017-R","article-title":"Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer\u2019s disease","volume":"13","author":"Blennow","year":"1992","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb0110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02815140","article-title":"Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?","volume":"26","author":"Blennow","year":"1995","journal-title":"Mol. Chem. Neuropathol."},{"issue":"5","key":"10.1016\/j.exger.2021.111452_bb0115","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.18632\/aging.101852","article-title":"Ventral tegmental area disruption in Alzheimer\u2019s disease","volume":"11","author":"Bozzali","year":"2019","journal-title":"Aging"},{"issue":"5","key":"10.1016\/j.exger.2021.111452_bb0120","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00401-011-0825-z","article-title":"Alzheimer\u2019s pathogenesis: is there neuron-to-neuron propagation?","volume":"121","author":"Braak","year":"2011","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb0125","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00002093-198903030-00004","article-title":"Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer dementia","volume":"3","author":"Br\u00e5ne","year":"1989","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"2","key":"10.1016\/j.exger.2021.111452_bb0130","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0006-8993(98)01211-6","article-title":"Accumulation of 3,4-dihydroxyphenylglycolaldehyde, the neurotoxic monoamine oxidase a metabolite of norepinephrine, in locus ceruleus cell bodies in Alzheimer\u2019s disease: mechanism of neuron death","volume":"816","author":"Burke","year":"1999","journal-title":"Brain Res."},{"issue":"8","key":"10.1016\/j.exger.2021.111452_bb0135","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1212\/01.WNL.0000158423.05224.7F","article-title":"The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs","volume":"64","author":"Burns","year":"2005","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.exger.2021.111452_bb0145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12017-012-8180-3","article-title":"Opioid system and Alzheimer\u2019s disease","volume":"14","author":"Cai","year":"2012","journal-title":"NeuroMolecular Med."},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s40292-015-0108-1","article-title":"Pathophysiological links among hypertension and Alzheimer\u2019s disease","volume":"23","author":"Carnevale","year":"2016","journal-title":"High Blood Pressure Cardiovasc. Prevent."},{"issue":"5","key":"10.1016\/j.exger.2021.111452_bb0155","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jalz.2013.05.1762","article-title":"Revisiting the framework of the National Institute on Aging-Alzheimer\u2019s Association diagnostic criteria","volume":"9","author":"Carrillo","year":"2013","journal-title":"Alzheimers Dementia J. Alzheimers Assoc."},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb0160","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1742-4933-9-20","article-title":"Alzheimer disease and platelets: how\u2019s that relevant","volume":"9","author":"Catricala","year":"2012","journal-title":"Immun. Ageing I A"},{"issue":"6","key":"10.1016\/j.exger.2021.111452_bb0165","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1111\/j.1471-4159.1993.tb07459.x","article-title":"Plasma 5-hydroxyindoleacetic acid as an indicator of monoamine oxidase-A inhibition in rat brain and peripheral tissues","volume":"61","author":"Celada","year":"1993","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.exger.2021.111452_bb0175","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2990.2000.00254.x","article-title":"Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer\u2019s disease prospectively assessed for behavioural changes","volume":"26","author":"Chen","year":"2000","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"23","key":"10.1016\/j.exger.2021.111452_bb0180","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1002\/elps.200600126","article-title":"Analysis of biologically active amines by CE","volume":"27","author":"Chiu","year":"2006","journal-title":"Electrophoresis"},{"issue":"4","key":"10.1016\/j.exger.2021.111452_bb0185","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00005072-198407000-00001","article-title":"Nucleus raphe dorsalis in dementia of the Alzheimer type: neurofibrillary changes and neuronal packing density","volume":"43","author":"Curcio","year":"1984","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"11","key":"10.1016\/j.exger.2021.111452_bb0190","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/s41562-019-0715-2","article-title":"Rostral locus coeruleus integrity is associated with better memory performance in older adults","volume":"3","author":"Dahl","year":"2019","journal-title":"Nat. Hum. Behav."},{"issue":"Suppl. 232","key":"10.1016\/j.exger.2021.111452_bb0195","first-page":"1","article-title":"Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons","author":"Dahlstroem","year":"1964","journal-title":"Acta Physiol. Scand. Suppl."},{"key":"10.1016\/j.exger.2021.111452_bb0200","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev.neuro.051508.135607","article-title":"Serotonin in affective control","volume":"32","author":"Dayan","year":"2009","journal-title":"Annu. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb0205","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3233\/JAD-171018","article-title":"Volume and connectivity of the ventral tegmental area are linked to neurocognitive signatures of Alzheimer\u2019s disease in humans","volume":"63","author":"De Marco","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"10","key":"10.1016\/j.exger.2021.111452_bb0210","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/0006-3223(90)90055-7","article-title":"Correlations between cisternal CSF and plasma concentrations of HVA, MHPG, 5-HIAA, DA, and NA","volume":"27","author":"Degrell","year":"1990","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb0215","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3233\/JAD-140783","article-title":"Serum MHPG strongly predicts conversion to Alzheimer\u2019s disease in behaviorally characterized subjects with down syndrome","volume":"43","author":"Dekker","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb0220","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3233\/ADR-170021","article-title":"Optimal cut-off value for locus coeruleus-to-pons intensity ratio as clinical biomarker for Alzheimer\u2019s disease: a pilot study","volume":"1","author":"Dordevic","year":"2017","journal-title":"J. Alzheimers Dis. Rep."},{"issue":"5","key":"10.1016\/j.exger.2021.111452_bb0225","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/nan.12387","article-title":"Quantifying the accretion of hyperphosphorylated tau in the locus coeruleus and dorsal raphe nucleus: the pathological building blocks of early Alzheimer\u2019s disease","volume":"43","author":"Ehrenberg","year":"2017","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"15","key":"10.1016\/j.exger.2021.111452_bb0230","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.febslet.2015.05.054","article-title":"The roles of peripheral serotonin in metabolic homeostasis","volume":"589","author":"El-Merahbi","year":"2015","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb0235","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1176\/ajp.154.1.25","article-title":"Effects of Alzheimer\u2019s disease severity on cerebrospinal fluid norepinephrine concentration","volume":"154","author":"Elrod","year":"1997","journal-title":"Am. J. Psychiatry"},{"issue":"3 Pt 2","key":"10.1016\/j.exger.2021.111452_bb0240","doi-asserted-by":"crossref","first-page":"140S","DOI":"10.1093\/ajh\/2.3.140S","article-title":"Noradrenaline release and the pathophysiology of primary human hypertension","volume":"2","author":"Esler","year":"1989","journal-title":"Am. J. Hypertens."},{"issue":"10","key":"10.1016\/j.exger.2021.111452_bb0245","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2174\/1570159X17666190409144558","article-title":"Monoamines and their derivatives on GPCRs: potential therapy for Alzheimer\u2019s disease","volume":"16","author":"Farf\u00e1n-Garc\u00eda","year":"2019","journal-title":"Curr. Alzheimer Res."},{"issue":"October","key":"10.1016\/j.exger.2021.111452_bb0250","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/jnc.13447","article-title":"Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system","volume":"139","author":"Feinstein","year":"2016","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.exger.2021.111452_bb0255","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jalz.2012.01.001","article-title":"Improved protocol for measurement of plasma \u03b2-amyloid in longitudinal evaluation of Alzheimer\u2019s disease neuroimaging Initiative study patients","volume":"8","author":"Figurski","year":"2012","journal-title":"Alzheimers Dementia J. Alzheimers Assoc."},{"issue":"11","key":"10.1016\/j.exger.2021.111452_bb0260","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1111\/ejn.12587","article-title":"Role of paraventricular nucleus-projecting norepinephrine\/epinephrine neurons in acute and chronic stress","volume":"39","author":"Flak","year":"2014","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.exger.2021.111452_bb0265","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00726-006-0409-8","article-title":"Free amino acid and dipeptide changes in the body fluids from Alzheimer\u2019s disease subjects","volume":"32","author":"Fonteh","year":"2007","journal-title":"Amino Acids"},{"issue":"S121","key":"10.1016\/j.exger.2021.111452_bb0270","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0404.1989.tb04875.x","article-title":"Early stages of late onset Alzheimer\u2019s disease","volume":"79","author":"Forssell","year":"1989","journal-title":"Acta Neurol. Scand."},{"issue":"4","key":"10.1016\/j.exger.2021.111452_bb0275","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1017\/S0033291700038459","article-title":"Clinical and neuropathological correlates of depression in Alzheimer\u2019s disease","volume":"22","author":"F\u00f6rstl","year":"1992","journal-title":"Psychol. Med."},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb0280","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/cne.903210309","article-title":"Restoration of ascending noradrenergic projections by residual locus coeruleus neurons: compensatory response to neurotoxin-induced cell death in the adult rat brain","volume":"321","author":"Fritschy","year":"1992","journal-title":"J. Comp. Neurol."},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb0285","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-020-01087-7","article-title":"Locus coeruleus magnetic resonance imaging in neurological diseases","volume":"21","author":"Galgani","year":"2020","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.exger.2021.111452_bb0290","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2015.00220","article-title":"Noradrenergic dysfunction in Alzheimer\u2019s disease","volume":"9","author":"Gannon","year":"2015","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb0295","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.neuropsychologia.2004.06.007","article-title":"Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer\u2019s disease","volume":"43","author":"Garcia-Alloza","year":"2005","journal-title":"Neuropsychologia"},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb0300","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-019-0511-2","article-title":"An experimental model of Braak\u2019s pretangle proposal for the origin of Alzheimer\u2019s disease: the role of locus coeruleus in early symptom development","volume":"11","author":"Ghosh","year":"2019","journal-title":"Alzheimers Res. Ther."},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb0305","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2007.09.023","article-title":"The normal equilibrium between CSF and plasma amyloid beta levels is disrupted in Alzheimer\u2019s disease","volume":"427","author":"Giedraitis","year":"2007","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.exger.2021.111452_bb0310","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3233\/JAD-170485","article-title":"Kynurenine pathway metabolites in Alzheimer\u2019s disease","volume":"60","author":"Giil","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.exger.2021.111452_bb0315","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2017.00080","article-title":"The neuroanatomy of the reticular nucleus locus coeruleus in Alzheimer\u2019s disease","volume":"11","author":"Giorgi","year":"2017","journal-title":"Front. Neuroanat."},{"issue":"November","key":"10.1016\/j.exger.2021.111452_bb0320","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.brainresbull.2019.08.007","article-title":"The role of locus coeruleus in neuroinflammation occurring in Alzheimer\u2019s disease","volume":"153","author":"Giorgi","year":"2019","journal-title":"Brain Res. Bull."},{"issue":"12","key":"10.1016\/j.exger.2021.111452_bb0325","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1002\/jnr.24718","article-title":"Locus coeruleus and neurovascular unit: from its role in physiology to its potential role in Alzheimer\u2019s disease pathogenesis","volume":"98","author":"Giorgi","year":"2020","journal-title":"J. Neurosci. Res."},{"issue":"January","key":"10.1016\/j.exger.2021.111452_bb0330","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1471-4159.1965.tb10247.x","article-title":"Metabolism of (H3)norepinephrine in the rat brain","volume":"12","author":"Glowinski","year":"1965","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb0335","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1124\/jpet.103.049270","article-title":"Sources and significance of plasma levels of catechols and their metabolites in humans","volume":"305","author":"Goldstein","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.exger.2021.111452_bb0340","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/01.HYP.5.4.552","article-title":"Relationship between plasma norepinephrine and sympathetic neural activity","volume":"5","author":"Goldstein","year":"1983","journal-title":"Hypertension (Dallas, Tex.: 1979)"},{"issue":"March","key":"10.1016\/j.exger.2021.111452_bb0345","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jpba.2014.10.010","article-title":"Metabolite profiling for the identification of altered metabolic pathways in Alzheimer\u2019s disease","volume":"107","author":"Gonz\u00e1lez-Dom\u00ednguez","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"9","key":"10.1016\/j.exger.2021.111452_bb0350","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/j.1471-4159.1969.tb05984.x","article-title":"Homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid of patients with senile dementia, presenile dementia and parkinsonism","volume":"16","author":"Gottfries","year":"1969","journal-title":"J. Neurochem."},{"issue":"3\u20135","key":"10.1016\/j.exger.2021.111452_bb0355","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0278-5846(86)90014-X","article-title":"Multiple biochemical deficits in both gray and white matter of Alzheimer brains","volume":"10","author":"Gottfries","year":"1986","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.exger.2021.111452_bb0360","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2990.2008.00997.x","article-title":"The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer\u2019s disease. A precocious onset?","volume":"35","author":"Grinberg","year":"2009","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb0365","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.neurobiolaging.2006.02.007","article-title":"Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer\u2019s disease","volume":"28","author":"Grudzien","year":"2007","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb0370","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2174\/1381612043386473","article-title":"Functional neurochemistry of Alzheimers disease","volume":"10","author":"Gsell","year":"2004","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.exger.2021.111452_bb0375","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2478\/v10039-010-0023-6","article-title":"Kynurenine and its metabolites in Alzheimer\u2019s disease patients","volume":"55","author":"Gulaj","year":"2010","journal-title":"Adv. Med. Sci."},{"issue":"6","key":"10.1016\/j.exger.2021.111452_bb0380","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/BF00227741","article-title":"Brain stem serotonin-synthesizing neurons in Alzheimer\u2019s disease: a clinicopathological correlation","volume":"84","author":"Halliday","year":"1992","journal-title":"Acta Neuropathol."},{"issue":"7","key":"10.1016\/j.exger.2021.111452_bb0385","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.mp.4001473","article-title":"Value of CSF beta-Amyloid1-42 and tau as predictors of Alzheimer\u2019s disease in patients with mild cognitive impairment","volume":"9","author":"Hampel","year":"2004","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb0390","first-page":"44","article-title":"A quantitative analysis of brain soluble tau and the tau secretion factor","volume":"76","author":"Han","year":"2017","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb0395","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-27031-x","article-title":"Comparative evaluation of MS-based metabolomics software and its application to preclinical Alzheimer\u2019s disease","volume":"8","author":"Hao","year":"2018","journal-title":"Sci. Rep."},{"issue":"5054","key":"10.1016\/j.exger.2021.111452_bb0400","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science (New York, N.Y.)"},{"issue":"4","key":"10.1016\/j.exger.2021.111452_bb0405","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0197-0186(85)90050-6","article-title":"Transmitter deficits in Alzheimer\u2019s disease","volume":"7","author":"Hardy","year":"1985","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.exger.2021.111452_bb0410","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-1-4684-3752-2_10","article-title":"Central adrenergic regulation of cerebral microvascular permeability and blood flow; anatomic and physiologic evidence","volume":"131","author":"Hartman","year":"1980","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.exger.2021.111452_bb7005","doi-asserted-by":"crossref","DOI":"10.2217\/bmm-2017-0388","article-title":"A review of biomarkers of Alzheimer\u2019s disease in noninvasive samples","author":"Hartmann","year":"2018","journal-title":"Biomark. Med."},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb0415","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-45168-1","article-title":"Rosmarinic acid suppresses Alzheimer\u2019s disease development by reducing amyloid \u03b2 aggregation by increasing monoamine secretion","volume":"9","author":"Hase","year":"2019","journal-title":"Sci. Rep."},{"issue":"13","key":"10.1016\/j.exger.2021.111452_bb0420","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1073\/pnas.0909586107","article-title":"Locus ceruleus controls Alzheimer\u2019s disease pathology by modulating microglial functions through norepinephrine","volume":"107","author":"Heneka","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.exger.2021.111452_bb0425","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.exger.2021.111452_bb0430","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jalz.2013.05.1775","article-title":"Addition of MHPG to Alzheimer\u2019s disease biomarkers improves differentiation of dementia with Lewy bodies from Alzheimer\u2019s disease but not other dementias","volume":"10","author":"Herbert","year":"2014","journal-title":"Alzheimers Dementia J. Alzheimers Assoc."},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb0435","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3233\/JAD-170458","article-title":"Plasma amyloid-\u03b2 levels, cerebral small vessel disease, and cognition: the Rotterdam study","volume":"60","author":"Hilal","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"5","key":"10.1016\/j.exger.2021.111452_bb0440","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000119457","article-title":"Prediction of Alzheimer\u2019s disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides","volume":"5","author":"H\u00f6glund","year":"2008","journal-title":"Neurodegener. Dis."},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb0445","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/1531-8249(199901)45:1<82::AID-ART14>3.0.CO;2-T","article-title":"Increased activity of surviving locus ceruleus neurons in Alzheimer\u2019s disease","volume":"45","author":"Hoogendijk","year":"1999","journal-title":"Ann. Neurol."},{"issue":"January","key":"10.1016\/j.exger.2021.111452_bb0450","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0378-4347(00)83003-0","article-title":"Determination of catecholamines in human plasma by high-performance liquid chromatography: comparison between a new method with fluorescence detection and an established method with electrochemical detection","volume":"487","author":"Hoorn","year":"1989","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.exger.2021.111452_bb0455","series-title":"Handbook of Behavioral Neuroscience","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1569-7339(10)70071-0","article-title":"The neuronatomy of the serotonergic system","volume":"21","author":"Hornung","year":"2010"},{"issue":"8","key":"10.1016\/j.exger.2021.111452_bb0460","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/WNL.52.8.1555","article-title":"Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF","volume":"52","author":"Hulstaert","year":"1999","journal-title":"Neurology"},{"issue":"August","key":"10.1016\/j.exger.2021.111452_bb0465","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.chroma.2013.06.005","article-title":"A new Metabolomic workflow for early detection of Alzheimer\u2019s disease","volume":"1302","author":"Ib\u00e1\u00f1ez","year":"2013","journal-title":"J. Chromatogr. A"},{"issue":"2","key":"10.1016\/j.exger.2021.111452_bb0470","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/BF00691428","article-title":"Morphological and biochemical changes in the cholinergic and monoaminergic systems in Alzheimer-type dementia","volume":"70","author":"Ichimiya","year":"1986","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.exger.2021.111452_bb0475","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232233","article-title":"Tyr-Trp administration facilitates brain norepinephrine metabolism and ameliorates a short-term memory deficit in a mouse model of Alzheimer\u2019s disease","volume":"15","author":"Ichinose","year":"2020","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.exger.2021.111452_bb0480","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/S0021-9258(19)77149-X","article-title":"Enzymic studies on the biosynthesis of serotonin in mammalian brain","volume":"245","author":"Ichiyama","year":"1970","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.exger.2021.111452_bb0485","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1136\/jnnp-2011-301628","article-title":"Retinal pathology as biomarker for cognitive impairment and Alzheimer\u2019s disease","volume":"83","author":"Ikram","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.exger.2021.111452_bb0490","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dementia J. Alzheimers Assoc."},{"key":"10.1016\/j.exger.2021.111452_bb0495","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fncir.2018.00051","article-title":"Monoaminergic neuromodulation of sensory processing","volume":"12","author":"Jacob","year":"2018","journal-title":"Front. Neural Circuits"},{"key":"10.1016\/j.exger.2021.111452_bb0500","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2019.03.015","article-title":"Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer\u2019s disease and relationship to amyloid-\u03b2 and tau","volume":"80","author":"Jacobs","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.exger.2021.111452_bb0505","doi-asserted-by":"crossref","DOI":"10.1038\/srep26801","article-title":"Plasma \u03b2-amyloid in Alzheimer\u2019s disease and vascular disease","volume":"6","author":"Janelidze","year":"2016","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.exger.2021.111452_bb0510","doi-asserted-by":"crossref","first-page":"e867","DOI":"10.1212\/WNL.0000000000006082","article-title":"CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease","volume":"91","author":"Janelidze","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.exger.2021.111452_bb0515","first-page":"172","article-title":"Cerebrospinal fluid and serum MHPG improve Alzheimer\u2019s disease versus dementia with Lewy bodies differential diagnosis","volume":"10","author":"Janssens","year":"2018","journal-title":"Alzheimers Dementia (Amsterdam, Netherlands)"},{"issue":"4","key":"10.1016\/j.exger.2021.111452_bb0520","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.neuint.2010.02.001","article-title":"Induced LC degeneration in APP\/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits","volume":"57","author":"Jardanhazi-Kurutz","year":"2010","journal-title":"Neurochem. Int."},{"issue":"March","key":"10.1016\/j.exger.2021.111452_bb0525","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.neuroscience.2010.11.052","article-title":"Distinct adrenergic system changes and neuroinflammation in response to induced locus ceruleus degeneration in APP\/PS1 transgenic mice","volume":"176","author":"Jardanhazi-Kurutz","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.exger.2021.111452_bb0530","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbr.2017.12.025","article-title":"Understanding the pathophysiology of depression: from monoamines to the neurogenesis hypothesis model - are we there yet?","volume":"341","author":"Jesulola","year":"2018","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb0535","first-page":"86","article-title":"Plasma and CSF MHPG in normals [proceedings]","volume":"17","author":"Jimerson","year":"1981","journal-title":"Psychopharmacol. Bull."},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb0540","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jalz.2010.06.001","article-title":"Metabolomic changes in autopsy-confirmed Alzheimer\u2019s disease","volume":"7","author":"Kaddurah-Daouk","year":"2011","journal-title":"Alzheimers Dementia J. Alzheimers Assoc."},{"issue":"April","key":"10.1016\/j.exger.2021.111452_bb0545","article-title":"Alterations in metabolic pathways and networks in Alzheimer\u2019s disease","volume":"3","author":"Kaddurah-Daouk","year":"2013","journal-title":"Transl. Psychiatry"},{"issue":"12","key":"10.1016\/j.exger.2021.111452_bb0550","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1111\/j.1460-9568.2006.05223.x","article-title":"Degeneration of noradrenergic fibres from the locus coeruleus causes tight-junction disorganisation in the rat brain","volume":"24","author":"Kalinin","year":"2006","journal-title":"Eur. J. Neurosci."},{"issue":"8","key":"10.1016\/j.exger.2021.111452_bb0555","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.neurobiolaging.2006.06.003","article-title":"Noradrenaline deficiency in brain increases \u03b2-amyloid plaque burden in an animal model of Alzheimer\u2019s disease","volume":"28","author":"Kalinin","year":"2007","journal-title":"Neurobiol. Aging"},{"issue":"8","key":"10.1016\/j.exger.2021.111452_bb0560","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s00415-002-0753-x","article-title":"Assessment of CSF homovanillic acid levels distinguishes dementia with Lewy bodies from Alzheimer\u2019s disease","volume":"249","author":"Kanemaru","year":"2002","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb0565","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1172\/JCI130513","article-title":"Norepinephrine metabolite DOPEGAL activates AEP and pathological tau aggregation in locus coeruleus","volume":"130","author":"Kang","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"January","key":"10.1016\/j.exger.2021.111452_bb0570","article-title":"Locus coeruleus cellular and molecular pathology during the progression of Alzheimer\u2019s disease","volume":"5","author":"Kelly","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"issue":"2","key":"10.1016\/j.exger.2021.111452_bb0575","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3233\/JAD-190090","article-title":"Locus coeruleus degeneration induces forebrain vascular pathology in a transgenic rat model of Alzheimer\u2019s disease","volume":"70","author":"Kelly","year":"2019","journal-title":"J. Alzheimers Dis."},{"issue":"51","key":"10.1016\/j.exger.2021.111452_bb0580","doi-asserted-by":"crossref","first-page":"14835","DOI":"10.1073\/pnas.1616515114","article-title":"Dopamine release from the locus coeruleus to the dorsal hippocampus promotes spatial learning and memory","volume":"113","author":"Kempadoo","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb0585","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1460-9568.2003.02716.x","article-title":"Hippocampal dopamine D2 receptors correlate with memory functions in Alzheimer\u2019s disease","volume":"18","author":"Kemppainen","year":"2003","journal-title":"Eur. J. Neurosci."},{"issue":"24","key":"10.1016\/j.exger.2021.111452_bb0590","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/0024-3205(82)90447-7","article-title":"Influence of dopamine agonists on plasma and brain levels of homovanillic acid","volume":"30","author":"Kendler","year":"1982","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb0595","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10571-018-0632-3","article-title":"Dopamine: functions, signaling, and association with neurological diseases","volume":"39","author":"Klein","year":"2019","journal-title":"Cell. Mol. Neurobiol."},{"issue":"4580","key":"10.1016\/j.exger.2021.111452_bb0600","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1126\/science.6849119","article-title":"Relation between plasma and cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylglycol","author":"Kopin","year":"1983","journal-title":"Science (New York, N.Y.)"},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb0605","doi-asserted-by":"crossref","first-page":"B93","DOI":"10.1093\/geronj\/48.3.B93","article-title":"Uptake of serotonin into platelets of senile dementia of the Alzheimer type patients","volume":"48","author":"Koren","year":"1993","journal-title":"J. Gerontol."},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb0610","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1006\/bbrc.2000.2222","article-title":"Amyloid-beta peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma","volume":"268","author":"Kuo","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.exger.2021.111452_bb0615","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1474-4422(05)70099-5","article-title":"Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis","volume":"4","author":"Kuo","year":"2005","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb0620","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0024-3205(95)00269-C","article-title":"Regional 5-hydroxyindoleacetic acid production in humans","volume":"57","author":"Lambert","year":"1995","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb0625","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0006-3223(94)00259-6","article-title":"Plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) and clinical symptoms in Alzheimer\u2019s disease","volume":"38","author":"Lawlor","year":"1995","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.exger.2021.111452_bb0630","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.neuint.2009.08.006","article-title":"No correlation between time-linked plasma and CSF A\u03b2 levels","volume":"55","author":"Le Bastard","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.exger.2021.111452_bb0635","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fnmol.2018.00254","article-title":"Noradrenergic hypothesis linking neurodegeneration-based cognitive decline and astroglia","volume":"11","author":"Leanza","year":"2018","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb0640","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/1389203711314010005","article-title":"Neurotransmitters and microglial-mediated neuroinflammation","volume":"14","author":"Lee","year":"2013","journal-title":"Curr. Protein Pept. Sci."},{"issue":"10","key":"10.1016\/j.exger.2021.111452_bb0650","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/jssc.201000799","article-title":"Simultaneous determination of catecholamines and their metabolites related to Alzheimer\u2019s disease in human urine","volume":"34","author":"Liu","year":"2011","journal-title":"J. Sep. Sci."},{"issue":"6","key":"10.1016\/j.exger.2021.111452_bb0655","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1600-0447.1988.tb05189.x","article-title":"Locus ceruleus morphometry in aging and schizophrenia","volume":"77","author":"Lohr","year":"1988","journal-title":"Acta Psychiatr. Scand."},{"issue":"2","key":"10.1016\/j.exger.2021.111452_bb0660","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1468-1331.1996.tb00209.x","article-title":"Relationship between CSF neurotransmitter metabolites and aggressive behavior in Alzheimer\u2019s disease","volume":"3","author":"Lopez","year":"1996","journal-title":"Eur. J. Neurol."},{"issue":"19","key":"10.1016\/j.exger.2021.111452_bb0665","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1212\/01.wnl.0000306696.82017.66","article-title":"Plasma amyloid levels and the risk of AD in normal subjects in the cardiovascular health study","volume":"70","author":"Lopez","year":"2008","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.exger.2021.111452_bb0670","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/jms.3536","article-title":"Determination of catecholamines and their metabolites in rat urine by ultra-performance liquid chromatography-tandem mass spectrometry for the study of identifying potential markers for Alzheimer\u2019s disease","volume":"50","author":"Lv","year":"2015","journal-title":"J. Mass Spectrom. JMS"},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb0675","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0197-4580(02)00057-X","article-title":"Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis","volume":"24","author":"Lyness","year":"2003","journal-title":"Neurobiol. Aging"},{"issue":"April","key":"10.1016\/j.exger.2021.111452_bb0680","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.semcdb.2015.03.002","article-title":"The kynurenine pathway and neurodegenerative disease","volume":"40","author":"Maddison","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.exger.2021.111452_bb0685","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0378-4347(00)00285-1","article-title":"Liquid chromatography-electrospray tandem mass spectrometry of acidic monoamine metabolites","volume":"744","author":"Manini","year":"2000","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb0690","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.neurobiolaging.2010.03.023","article-title":"Loss of serotonin 2A receptors exceeds loss of serotonergic projections in early Alzheimer\u2019s disease: a combined [11C]DASB and [18F]altanserin-PET study","volume":"33","author":"Marner","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb0695","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF02251133","article-title":"Monoamines and related metabolite levels in the cerebrospinal fluid of patients with dementia of Alzheimer type. Influence of treatment with L-deprenyl","volume":"3","author":"Martignoni","year":"1991","journal-title":"J. Neural Transm. Park. Dis. Dement. Sect."},{"key":"10.1016\/j.exger.2021.111452_bb0700","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fnagi.2014.00252","article-title":"Is dopamine involved in Alzheimer\u2019s disease?","volume":"6","author":"Martorana","year":"2014","journal-title":"Front. Aging Neurosci."},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb0705","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.tics.2016.01.001","article-title":"The locus coeruleus: essential for maintaining cognitive function and the aging brain","volume":"20","author":"Mather","year":"2016","journal-title":"Trends Cogn. Sci."},{"issue":"10","key":"10.1016\/j.exger.2021.111452_bb0710","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.15252\/emmm.201606540","article-title":"Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer\u2019s disease","volume":"8","author":"Mattsson","year":"2016","journal-title":"EMBO Mol. Med."},{"issue":"17","key":"10.1016\/j.exger.2021.111452_bb0715","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1212\/WNL.0000000000003246","article-title":"Plasma tau in Alzheimer disease","volume":"87","author":"Mattsson","year":"2016","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.exger.2021.111452_bb0720","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","article-title":"Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol."},{"issue":"9","key":"10.1016\/j.exger.2021.111452_bb0725","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1212\/01.WNL.0000091890.32140.8F","article-title":"Plasma A 40 and A 42 and Alzheimer\u2019s disease: relation to age, mortality, and risk","volume":"61","author":"Mayeux","year":"2003","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.exger.2021.111452_bb0730","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb0735","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1478-811X-11-34","article-title":"Complexity of dopamine metabolism","volume":"11","author":"Meiser","year":"2013","journal-title":"Cell Commun. Signal. CCS"},{"issue":"4","key":"10.1016\/j.exger.2021.111452_bb0740","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-0404.1984.tb07804.x","article-title":"Monoamine metabolites in human cerebrospinal fluid. HPLC\/ED method","volume":"69","author":"Mena","year":"1984","journal-title":"Acta Neurol. Scand."},{"issue":"5\u20136","key":"10.1016\/j.exger.2021.111452_bb0745","first-page":"543","article-title":"Serotonin and emotion, learning and memory","volume":"23","author":"Meneses","year":"2012","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.exger.2021.111452_bb0750","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0079-6123(08)00912-6","article-title":"The dorsal raphe nucleus and serotonin: implications for neuroplasticity linked to major depression and Alzheimer\u2019s disease","volume":"172","author":"Michelsen","year":"2008","journal-title":"Prog. Brain Res."},{"issue":"15","key":"10.1016\/j.exger.2021.111452_bb0755","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.clinbiochem.2014.07.007","article-title":"Alzheimer and platelets: low-density platelet populations reveal increased serotonin content in Alzheimer type dementia","volume":"47","author":"Milovanovic","year":"2014","journal-title":"Clin. Biochem."},{"issue":"11","key":"10.1016\/j.exger.2021.111452_bb0760","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/0006-3223(91)90253-I","article-title":"CSF monoamine metabolites and somatostatin in Alzheimer\u2019s disease and major depression","volume":"29","author":"Molchan","year":"1991","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.exger.2021.111452_bb0765","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/ene.13374","article-title":"Hypertension is associated with worse cognitive function and hippocampal hypometabolism in Alzheimer\u2019s disease","volume":"24","author":"Moonga","year":"2017","journal-title":"Eur. J. Neurol."},{"issue":"6","key":"10.1016\/j.exger.2021.111452_bb0770","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jalz.2019.03.007","article-title":"Inflammatory biomarkers in Alzheimer\u2019s disease plasma","volume":"15","author":"Morgan","year":"2019","journal-title":"Alzheimers Dementia J. Alzheimers Assoc."},{"key":"10.1016\/j.exger.2021.111452_bb0775","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3389\/fphar.2019.00483","article-title":"Monoaminergic system modulation in depression and Alzheimer\u2019s disease: a new standpoint?","volume":"10","author":"Morgese","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.exger.2021.111452_bb0780","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171524","article-title":"Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer\u2019s disease: an autopsy-confirmed study","volume":"12","author":"Morimoto","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.exger.2021.111452_bb0785","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.bbadis.2014.04.012","article-title":"Is Alzheimer\u2019s disease a systemic disease?","volume":"1842","author":"Morris","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.exger.2021.111452_bb0790","series-title":"Biochemistry of Biogenic Amines","first-page":"1","article-title":"Enzymes involved in the biosynthesis and degradation of catecholamines","author":"Musacchio","year":"1975"},{"issue":"July","key":"10.1016\/j.exger.2021.111452_bb0795","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pnpbp.2013.02.002","article-title":"Genotype-independent decrease in plasma dopamine beta-hydroxylase activity in Alzheimer\u2019s disease","volume":"44","author":"Mustapic","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.exger.2021.111452_bb0800","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0304-3940(81)90027-6","article-title":"Divergent projections of catecholamine neurons of the locus coeruleus as revealed by fluorescent retrograde double labeling technique","volume":"23","author":"Nagai","year":"1981","journal-title":"Neurosci. Lett."},{"issue":"7691","key":"10.1016\/j.exger.2021.111452_bb0805","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-\u03b2 biomarkers for Alzheimer\u2019s disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.exger.2021.111452_bb0810","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1021\/acschemneuro.8b00122","article-title":"Regulatory activities of dopamine and its derivatives toward metal-free and metal-induced amyloid-\u03b2 aggregation, oxidative stress, and inflammation in Alzheimer\u2019s disease","volume":"9","author":"Nam","year":"2018","journal-title":"ACS Chem. Neurosci."},{"issue":"6","key":"10.1016\/j.exger.2021.111452_bb0815","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF00711237","article-title":"Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer\u2019s disease: a postmortem study","volume":"12","author":"Nazarali","year":"1992","journal-title":"Cell. Mol. Neurobiol."},{"issue":"10","key":"10.1016\/j.exger.2021.111452_bb0820","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nrneurol.2015.172","article-title":"Monoamine neurotransmitter disorders\u2014clinical advances and future perspectives","volume":"11","author":"Ng","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.exger.2021.111452_bb0825","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14727","article-title":"Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer\u2019s disease","volume":"8","author":"Nobili","year":"2017","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.exger.2021.111452_bb0830","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jalz.2014.08.099","article-title":"Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer\u2019s disease research","volume":"11","author":"O\u2019Bryant","year":"2015","journal-title":"Alzheimers Dementia J. Alzheimers Assoc."},{"key":"10.1016\/j.exger.2021.111452_bb0835","unstructured":"O'Connor, David. n.d. \u201cWorld Alzheimer Report 2019: Attitudes to Dementia,\u201d 160."},{"issue":"2","key":"10.1016\/j.exger.2021.111452_bb0840","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3233\/JAD-180325","article-title":"Glial fibrillary acidic protein in serum is increased in Alzheimer\u2019s disease and correlates with cognitive impairment","volume":"67","author":"Oeckl","year":"2019","journal-title":"J. Alzheimers Dis."},{"issue":"7","key":"10.1016\/j.exger.2021.111452_bb0845","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/acn3.50818","article-title":"Early alteration of the locus coeruleus in phenotypic variants of Alzheimer\u2019s disease","volume":"6","author":"Olivieri","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"2","key":"10.1016\/j.exger.2021.111452_bb0850","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/29.2.7019303","article-title":"Ultrastructural demonstration of noradrenergic synapses in the rat central nervous system by dopamine-beta-hydroxylase immunocytochemistry","volume":"29","author":"Olschowka","year":"1981","journal-title":"J. Histochem. Cytochem. Off. J. Histochem. Soc."},{"issue":"7","key":"10.1016\/j.exger.2021.111452_bb0855","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.exger.2021.111452_bb0860","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jnnp.47.5.481","article-title":"Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer\u2019s dementia","volume":"47","author":"Palmer","year":"1984","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.exger.2021.111452_bb0865","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0006-8993(87)90018-7","article-title":"Catecholaminergic neurones assessed ante-mortem in Alzheimer\u2019s disease","volume":"414","author":"Palmer","year":"1987","journal-title":"Brain Res."},{"issue":"February","key":"10.1016\/j.exger.2021.111452_bb0870","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neurobiolaging.2015.11.014","article-title":"Alzheimer\u2019s disease-like pathology has transient effects on the brain and blood metabolome","volume":"38","author":"Pan","year":"2016","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb0875","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0304-3940(87)90414-9","article-title":"Monoaminergic fibers form conventional synapses in the cerebral cortex","volume":"76","author":"Papadopoulos","year":"1987","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb0880","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01188418","article-title":"Light and electron microscopic Immunocytochemical analysis of the noradrenaline innervation of the rat visual cortex","volume":"18","author":"Papadopoulos","year":"1989","journal-title":"J. Neurocytol."},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb0885","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/icb\/24.3.783","article-title":"Functional anatomy and evolution of monoaminergic systems","volume":"24","author":"Parent","year":"1984","journal-title":"Am. Zool."},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb0890","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13195-017-0248-8","article-title":"Chemically treated plasma A\u03b2 is a potential blood-based biomarker for screening cerebral amyloid deposition","volume":"9","author":"Park","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.exger.2021.111452_bb0895","article-title":"New fluid biomarkers tracking non-amyloid-\u03b2 and non-tau pathology in Alzheimer\u2019s disease","volume":"April","author":"Park","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"5","key":"10.1016\/j.exger.2021.111452_bb0900","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1600-0447.1987.tb02831.x","article-title":"Monoamines and their metabolites in cerebrospinal fluid of patients with senile dementia of Alzheimer type using high performance liquid chromatography and gas chromatography-mass spectrometry","volume":"75","author":"Parnetti","year":"1987","journal-title":"Acta Psychiatr. Scand."},{"issue":"1\u20132","key":"10.1016\/j.exger.2021.111452_bb0905","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF03159966","article-title":"CSF monoamine metabolites in old age dementias","volume":"16","author":"Parnetti","year":"1992","journal-title":"Mol. Chem. Neuropathol."},{"issue":"Pt 1","key":"10.1016\/j.exger.2021.111452_bb0910","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1258\/000456304322664663","article-title":"Measurement of catecholamines and their metabolites","volume":"41","author":"Peaston","year":"2004","journal-title":"Ann. Clin. Biochem."},{"issue":"October","key":"10.1016\/j.exger.2021.111452_bb0915","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neurobiolaging.2017.06.002","article-title":"Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer\u2019s disease","volume":"58","author":"Pereira","year":"2017","journal-title":"Neurobiol. Aging"},{"issue":"44","key":"10.1016\/j.exger.2021.111452_bb0920","doi-asserted-by":"crossref","first-page":"10220","DOI":"10.1523\/JNEUROSCI.2773-05.2005","article-title":"Nigrostriatal dysfunction in familial Alzheimer\u2019s disease-linked APPswe\/PS1DeltaE9 transgenic mice","volume":"25","author":"Perez","year":"2005","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"issue":"9","key":"10.1016\/j.exger.2021.111452_bb0925","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/archpsyc.1995.03950210068012","article-title":"Effects of Alzheimer\u2019s disease and normal aging on cerebrospinal fluid norepinephrine responses to yohimbine and clonidine","volume":"52","author":"Peskind","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.exger.2021.111452_bb0930","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0306-4530(00)00041-X","article-title":"Plasma catecholamine and cardiovascular responses to physostigmine in Alzheimer\u2019s disease and aging","volume":"26","author":"Petrie","year":"2001","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb0935","article-title":"Correlation between cognition and plasma noradrenaline level in Alzheimer\u2019s disease: a potential new blood marker of disease evolution","volume":"10","author":"Pillet","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb0940","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1559-0275-11-12","article-title":"Distinct transthyretin oxidation isoform profile in spinal fluid from patients with Alzheimer\u2019s disease and mild cognitive impairment","volume":"11","author":"Poulsen","year":"2014","journal-title":"Clin. Proteomics"},{"issue":"9","key":"10.1016\/j.exger.2021.111452_bb0945","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1073\/pnas.72.9.3726","article-title":"Central noradrenergic regulation of cerebral blood flow and vascular permeability","volume":"72","author":"Raichle","year":"1975","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.exger.2021.111452_bb0950","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s40265-014-0217-5","article-title":"Serotonergic therapies for cognitive symptoms in Alzheimer\u2019s disease: rationale and current status","volume":"74","author":"Ramirez","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.exger.2021.111452_bb0955","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3389\/fnmol.2019.00334","article-title":"Dopamine and noradrenaline in the brain; overlapping or dissociate functions?","volume":"12","author":"Ranjbar-Slamloo","year":"2019","journal-title":"Front. Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.exger.2021.111452_bb0960","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archpsyc.1984.01790150033006","article-title":"Norepinephrine and MHPG levels in CSF and plasma in Alzheimer\u2019s disease","volume":"41","author":"Raskind","year":"1984","journal-title":"Arch. Gen. Psychiatry"},{"issue":"6","key":"10.1016\/j.exger.2021.111452_bb0965","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0006-3223(99)00008-6","article-title":"Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer\u2019s disease","volume":"46","author":"Raskind","year":"1999","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb0970","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jalz.2012.12.006","article-title":"Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer\u2019s disease","volume":"10","author":"Rembach","year":"2014","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1016\/j.exger.2021.111452_bb0975","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00213-002-1125-z","article-title":"High correlation between salivary MHPG and CSF MHPG","volume":"162","author":"Reuster","year":"2002","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb0980","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.neurobiolaging.2012.05.019","article-title":"A noradrenergic theory of cognitive reserve: implications for Alzheimer\u2019s disease","volume":"34","author":"Robertson","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb0985","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jalz.2008.10.004","article-title":"Amyloid Beta peptides in human plasma and tissues and their significance for Alzheimer\u2019s disease","volume":"5","author":"Roher","year":"2009","journal-title":"Alzheimers Dementia J. Alzheimers Assoc."},{"issue":"11","key":"10.1016\/j.exger.2021.111452_bb0990","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1093\/brain\/awx232","article-title":"Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer\u2019s disease","volume":"140","author":"Rorabaugh","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.exger.2021.111452_bb0995","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ynstr.2015.09.002","article-title":"Locus coeruleus, norepinephrine and A\u03b2 peptides in Alzheimer\u2019s disease","volume":"2","author":"Ross","year":"2015","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.exger.2021.111452_bb1000","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.pnpbp.2017.08.004","article-title":"Stress induced neural reorganization: a conceptual framework linking depression and Alzheimer\u2019s disease","volume":"85","author":"Ross","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.exger.2021.111452_bb1005","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s004010000320","article-title":"The autonomic higher order processing nuclei of the lower brain stem are among the early targets of the Alzheimer\u2019s disease-related cytoskeletal pathology","volume":"101","author":"R\u00fcb","year":"2001","journal-title":"Acta Neuropathol."},{"issue":"12","key":"10.1016\/j.exger.2021.111452_bb1010","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1210\/en.2010-0745","article-title":"Minireview: new roles for peripheral dopamine on metabolic control and tumor growth: let\u2019s seek the balance","volume":"151","author":"Rub\u00ed","year":"2010","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb1015","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0361-9230(92)90056-4","article-title":"The evidence for astrocytes as a target for central noradrenergic activity: expression of adrenergic receptors","volume":"29","author":"Salm","year":"1992","journal-title":"Brain Res. Bull."},{"issue":"1\u20132","key":"10.1016\/j.exger.2021.111452_bb1020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11010-005-7499-6","article-title":"Neurotoxic dopamine quinone facilitates the assembly of tau into fibrillar polymers","volume":"278","author":"Santa-Mar\u00eda","year":"2005","journal-title":"Mol. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb1025","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrn2573","article-title":"The locus coeruleus and noradrenergic modulation of cognition","volume":"10","author":"Sara","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"issue":"11","key":"10.1016\/j.exger.2021.111452_bb1030","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/01.wnr.0000227984.84927.a7","article-title":"Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson\u2019s disease","volume":"17","author":"Sasaki","year":"2006","journal-title":"Neuroreport"},{"key":"10.1016\/j.exger.2021.111452_bb1035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.brainres.2017.12.027","article-title":"Roles of tau pathology in the locus coeruleus (LC) in age-associated pathophysiology and Alzheimer\u2019s disease pathogenesis: potential strategies to protect the LC against aging","volume":"1702","author":"Satoh","year":"2019","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb1040","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1471-4159.1987.tb05582.x","article-title":"Tyrosine hydroxylase, tryptophan hydroxylase, biopterin, and neopterin in the brains of normal controls and patients with senile dementia of Alzheimer type","volume":"48","author":"Sawada","year":"1987","journal-title":"J. Neurochem."},{"issue":"10043","key":"10.1016\/j.exger.2021.111452_bb1045","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer\u2019s disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet (London, England)"},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb1050","first-page":"185","article-title":"Total and phospho-tau (Thr 181) CSF levels in patients with mild cognitive impairment and Alzheimer\u2019s disease","volume":"1","author":"Sch\u00f6nknecht","year":"2004","journal-title":"Psychoger. Pol."},{"issue":"21","key":"10.1016\/j.exger.2021.111452_bb1055","doi-asserted-by":"crossref","first-page":"R1051","DOI":"10.1016\/j.cub.2015.09.039","article-title":"Organization of the locus coeruleus-norepinephrine system","volume":"25","author":"Schwarz","year":"2015","journal-title":"Curr. Biol. CB"},{"key":"10.1016\/j.exger.2021.111452_bb1060","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neurobiolaging.2018.08.012","article-title":"In vivo mapping of brainstem nuclei functional connectivity disruption in Alzheimer\u2019s disease","volume":"72","author":"Serra","year":"2018","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb1065","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"2","key":"10.1016\/j.exger.2021.111452_bb1070","first-page":"155","article-title":"Higher cerebrospinal fluid MHPG in subjects with dementia of the Alzheimer type. Relationship with cognitive dysfunction","volume":"6","author":"Sheline","year":"1998","journal-title":"Am. J. Geriatric Psychiatry Off. J. Am. Assoc. Geriatric Psychiatry"},{"issue":"2","key":"10.1016\/j.exger.2021.111452_bb1075","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0006-8993(86)90226-X","article-title":"Cholinergic muscarinic binding by rat lymphocytes: effects of antagonist treatment, strain and aging","volume":"380","author":"Shenkman","year":"1986","journal-title":"Brain Res."},{"issue":"March","key":"10.1016\/j.exger.2021.111452_bb1080","article-title":"Hypertension accelerates Alzheimer\u2019s disease-related pathologies in pigs and 3xTg mice","volume":"10","author":"Shih","year":"2018","journal-title":"Front. Aging Neurosci."},{"issue":"6","key":"10.1016\/j.exger.2021.111452_bb1085","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2990.2009.01038.x","article-title":"Does Alzheimer\u2019s disease begin in the brainstem?","volume":"35","author":"Simic","year":"2009","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.exger.2021.111452_bb1090","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.pneurobio.2016.04.001","article-title":"Monoaminergic neuropathology in Alzheimer\u2019s disease","volume":"151","author":"\u0160imi\u0107","year":"2017","journal-title":"Prog. Neurobiol."},{"issue":"5","key":"10.1016\/j.exger.2021.111452_bb1095","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0197-4580(98)00086-4","article-title":"Decreased monoamine metabolites in frontotemporal dementia and Alzheimer\u2019s disease","volume":"19","author":"Sj\u00f6gren","year":"1998","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.exger.2021.111452_bb1100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1600-0404.1981.tb04392.x","article-title":"Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type","volume":"64","author":"Soininen","year":"1981","journal-title":"Acta Neurol. Scand."},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb1105","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dementia J. Alzheimers Assoc."},{"issue":"May","key":"10.1016\/j.exger.2021.111452_bb1110","article-title":"Catecholamine-based treatment in AD patients: expectations and delusions","volume":"7","author":"Stefani","year":"2015","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb1115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0304-3940(95)12256-7","article-title":"Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients","volume":"203","author":"Storga","year":"1996","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.exger.2021.111452_bb1120","first-page":"435","article-title":"5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer\u2019s disease, depression and mild cognitive impairment","volume":"25","author":"Stuerenburg","year":"2004","journal-title":"Neuro Endocrinol. Lett."},{"issue":"10","key":"10.1016\/j.exger.2021.111452_bb1125","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/s41593-018-0234-x","article-title":"The role of brain vasculature in neurodegenerative disorders","volume":"21","author":"Sweeney","year":"2018","journal-title":"Nat. Neurosci."},{"issue":"8","key":"10.1016\/j.exger.2021.111452_bb1130","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1177\/0269881113490326","article-title":"Functional neuroanatomy of the central noradrenergic system","volume":"27","author":"Szabadi","year":"2013","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.exger.2021.111452_bb1135","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1523\/JNEUROSCI.4265-05.2006","article-title":"Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer\u2019s disease and dementia with Lewy bodies","volume":"26","author":"Szot","year":"2006","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"issue":"2","key":"10.1016\/j.exger.2021.111452_bb1140","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3233\/JAD-160022","article-title":"Association of platelet serotonin levels in Alzheimer\u2019s disease with clinical and cerebrospinal fluid markers","volume":"53","author":"Tajeddinn","year":"2016","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb1145","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/ggi.12280","article-title":"Detection of changes in the locus coeruleus in patients with mild cognitive impairment and Alzheimer\u2019s disease: high-resolution fast spin-echo T1-weighted imaging","volume":"15","author":"Takahashi","year":"2015","journal-title":"Geriatr Gerontol Int"},{"issue":"7620","key":"10.1016\/j.exger.2021.111452_bb1150","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nature19325","article-title":"Locus Coeruleus and dopaminergic consolidation of everyday memory","volume":"537","author":"Takeuchi","year":"2016","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.exger.2021.111452_bb1155","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain-implications for Alzheimer disease","volume":"11","author":"Tarasoff-Conway","year":"2015","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.exger.2021.111452_bb1160","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.3233\/JAD-170784","article-title":"Plasma amyloid-\u03b2 (A\u03b242) correlates with cerebrospinal fluid A\u03b242 in Alzheimer\u2019s disease","volume":"62","author":"Teunissen","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb1165","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jalz.2016.06.2362","article-title":"Locus coeruleus volume and cell population changes during Alzheimer\u2019s disease progression: a stereological study in human postmortem brains with potential implication for early-stage biomarker discovery","volume":"13","author":"Theofilas","year":"2017","journal-title":"Alzheimers Dementia J. Alzheimers Assoc."},{"key":"10.1016\/j.exger.2021.111452_bb1170","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.nbd.2018.05.021","article-title":"Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer\u2019s disease","volume":"117","author":"Tiernan","year":"2018","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb1175","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF02257623","article-title":"Concentrations of monoamines and their metabolites in the cerebrospinal fluid from patients with senile dementia of the Alzheimer type and vascular dementia of the Binswanger type","volume":"4","author":"Tohgi","year":"1992","journal-title":"J. Neural Transm. Park. Dis. Dement. Sect."},{"issue":"8","key":"10.1016\/j.exger.2021.111452_bb1180","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.neubiorev.2013.05.008","article-title":"Ascending monoaminergic systems alterations in Alzheimer\u2019s disease. Translating basic science into clinical care","volume":"37","author":"Trillo","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"8","key":"10.1016\/j.exger.2021.111452_bb1185","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.bbadis.2013.06.014","article-title":"Recent advances in the application of metabolomics to Alzheimer\u2019s disease","volume":"1842","author":"Trushina","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.exger.2021.111452_bb1190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063644","article-title":"Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer\u2019s disease using metabolomics","volume":"8","author":"Trushina","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb1195","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s00216-006-0675-z","article-title":"Recent advances in methods for the analysis of catecholamines and their metabolites","volume":"386","author":"Tsunoda","year":"2006","journal-title":"Anal. Bioanal. Chem."},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb1200","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3940(00)01036-3","article-title":"Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization","volume":"285","author":"Vanmechelen","year":"2000","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.exger.2021.111452_bb1205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002482","article-title":"Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: a targeted metabolomics study","volume":"15","author":"Varma","year":"2018","journal-title":"PLoS Med."},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb1210","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3233\/JAD-140309","article-title":"Brain region-specific monoaminergic correlates of neuropsychiatric symptoms in Alzheimer\u2019s disease","volume":"41","author":"Vermeiren","year":"2014","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb1215","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3233\/JAD-160320","article-title":"\u201cBrain serotonergic and noradrenergic deficiencies in behavioral variant frontotemporal dementia compared to early-onset Alzheimer\u2019s disease.\u201d Edited by Gwenn Smith","volume":"53","author":"Vermeiren","year":"2016","journal-title":"J. Alzheimers Dis."},{"issue":"12","key":"10.1016\/j.exger.2021.111452_bb1220","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/archneur.1985.04060110040013","article-title":"Serotoninergic system in dementia of the Alzheimer type. Abnormal forms of 5-hydroxytryptophan and serotonin in cerebrospinal fluid","volume":"42","author":"Volicer","year":"1985","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.exger.2021.111452_bb1225","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3389\/fnagi.2018.00383","article-title":"Levels of cortisol in CSF are associated with SNAP-25 and tau pathology but not amyloid-\u03b2","volume":"10","author":"Wang","year":"2018","journal-title":"Front. Aging Neurosci."},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb1230","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/MOL.0b013e3283462273","article-title":"Role of peripheral serotonin in glucose and lipid metabolism","volume":"22","author":"Watanabe","year":"2011","journal-title":"Curr. Opin. Lipidol."},{"issue":"Pt 2","key":"10.1016\/j.exger.2021.111452_bb1235","first-page":"159","article-title":"Plasma amino acids in patients with senile dementia and in subjects with Down\u2019s syndrome at an age vulnerable to Alzheimer changes","volume":"33","author":"Watkins","year":"1989","journal-title":"J. Ment. Defic. Res."},{"key":"10.1016\/j.exger.2021.111452_bb1245","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3389\/fneur.2017.00719","article-title":"Application of metabolomics in Alzheimer\u2019s disease","volume":"8","author":"Wilkins","year":"2017","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.exger.2021.111452_bb1250","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3233\/JAD-141977","article-title":"Oxidative stress and aberrant cell cycle in Alzheimer\u2019s disease lymphocytes: diagnostic prospects","volume":"46","author":"Wojsiat","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.exger.2021.111452_bb1255","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1227\/00006123-198208000-00019","article-title":"Neuroendocrinology of cerebrospinal fluid: peptides, steroids, and other hormones","volume":"11","author":"Wood","year":"1982","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.exger.2021.111452_bb1260","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/ggi.12147","article-title":"Serum levels of albumin-amyloid beta complexes are decreased in Alzheimer\u2019s disease","volume":"14","author":"Yamamoto","year":"2014","journal-title":"Geriatr Gerontol Int"},{"issue":"4","key":"10.1016\/j.exger.2021.111452_bb1265","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3233\/JAD-170810","article-title":"Assay of plasma phosphorylated tau protein (threonine 181) and total tau protein in early-stage Alzheimer\u2019s disease","volume":"61","author":"Yang","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.exger.2021.111452_bb6005","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3233\/JAD-180261","article-title":"Urine-based biomarkers for Alzheimer\u2019s disease identified through coupling computational and experimental methods","volume":"65","author":"Yao","year":"2018","journal-title":"J. Alzheimers Dis. JAD"},{"key":"10.1016\/j.exger.2021.111452_bb1270","first-page":"1","article-title":"Human neuromelanin: an endogenous microglial activator for dopaminergic neuron death","volume":"5","author":"Zhang","year":"2013","journal-title":"Front. Biosci. (Elite Edit.)"},{"issue":"526","key":"10.1016\/j.exger.2021.111452_bb1275","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay6931","article-title":"\u03b2-Amyloid redirects norepinephrine signaling to activate the pathogenic GSK3\u03b2\/tau cascade","volume":"12","author":"Zhang","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"February","key":"10.1016\/j.exger.2021.111452_bb1280","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jpba.2016.11.056","article-title":"Analysis of amino acid and monoamine neurotransmitters and their metabolites in rat urine of Alzheimer\u2019s disease using in situ ultrasound-assisted derivatization dispersive liquid-liquid microextraction with UHPLC-MS\/MS","volume":"135","author":"Zhao","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"11","key":"10.1016\/j.exger.2021.111452_bb1285","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1001\/archneur.1988.00520350020008","article-title":"Major depression in primary dementia. Clinical and neuropathologic correlates","volume":"45","author":"Zubenko","year":"1988","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.exger.2021.111452_bb1290","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archneur.1990.00530020117023","article-title":"Neurochemical correlates of major depression in primary dementia","volume":"47","author":"Zubenko","year":"1990","journal-title":"Arch. Neurol."}],"container-title":["Experimental Gerontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556521002345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556521002345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T03:25:33Z","timestamp":1759980333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0531556521002345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":254,"alternative-id":["S0531556521002345"],"URL":"https:\/\/doi.org\/10.1016\/j.exger.2021.111452","relation":{},"ISSN":["0531-5565"],"issn-type":[{"value":"0531-5565","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New frontiers in Alzheimer's disease diagnostic: Monoamines and their derivatives in biological fluids","name":"articletitle","label":"Article Title"},{"value":"Experimental Gerontology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exger.2021.111452","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111452"}}